News

“Completing enrollment early, in partnership with Pfizer Ignite, for both the Phase 2 ACeD-it and the Phase 2a SynCeD trials of KAN-101 represents an important clinical milestone as we advance ...
Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease Provided by Business Wire May 27, 2025, 11:00:00 AM Conference call to be held later today at 8:30 a.m. ET ...